Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study.
Meneveau N, Schiele F, Grollier G, Farah B, Lablanche JM, Khalifé K, Machecourt J, Danchin N, Wolf JE, Simpson M, Hak JB, Bassand JP. Meneveau N, et al. Among authors: machecourt j. Eur Heart J. 2000 Nov;21(21):1767-75. doi: 10.1053/euhj.1999.2041. Eur Heart J. 2000. PMID: 11052841 Clinical Trial.
Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
Bertrand ME, McFadden EP, Fruchart JC, Van Belle E, Commeau P, Grollier G, Bassand JP, Machecourt J, Cassagnes J, Mossard JM, Vacheron A, Castaigne A, Danchin N, Lablanche JM. Bertrand ME, et al. Among authors: machecourt j. J Am Coll Cardiol. 1997 Oct;30(4):863-9. doi: 10.1016/s0735-1097(97)00259-3. J Am Coll Cardiol. 1997. PMID: 9316510 Free article. Clinical Trial.
"Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty.
Garbarz E, Farah B, Vuillemenot A, André F, Angioï M, Machecourt J, Bassand JP, Wolf JE, Danchin N, Prendergast B, Iung B, Vahanian A. Garbarz E, et al. Among authors: machecourt j. Am J Cardiol. 1998 Sep 15;82(6):800-3, A9. doi: 10.1016/s0002-9149(98)00459-7. Am J Cardiol. 1998. PMID: 9761094 Clinical Trial.
Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
Machecourt J, Danchin N, Lablanche JM, Fauvel JM, Bonnet JL, Marliere S, Foote A, Quesada JL, Eltchaninoff H, Vanzetto G; EVASTENT Investigators. Machecourt J, et al. J Am Coll Cardiol. 2007 Aug 7;50(6):501-8. doi: 10.1016/j.jacc.2007.04.051. Epub 2007 Jul 23. J Am Coll Cardiol. 2007. PMID: 17678732 Free article.
140 results